Results 81 to 90 of about 34,440,044 (184)

Glucagon-like Peptide-1 Receptor Agonists and the Perioperative Patient. [PDF]

AORN J
Fischer L.
europepmc   +1 more source

Glucagon-like peptide-1 Receptor Agonists for Weight Management in Mental Illness: A Network Meta-Analysis

This network meta-analysis of randomized controlled trials (RCTs) will aim to evaluate the comparative risk–benefit profiles of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in individuals with obesity comorbid with mental ...
Taro Kishi
core   +1 more source

Are Glucagon-Like Peptide-1 Receptor Agonists Suitable for Secondary Stroke Prevention? [PDF]

J Clin Neurol
Kwon HS, Koh SH.
europepmc   +1 more source

Glucagon-Like Peptide-1 Receptor Agonists for Arthritis and Osteoarthritis

Cureus
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) play a pivotal role in managing type 2 diabetes mellitus (T2DM), obesity, and other conditions, with proven benefits including, but not limited to, weight loss, glycemic control, and cardiovascular protection. However, their implications for arthritis are still debatable. GLP-1RAs may reduce systemic
openaire   +3 more sources

GLP-1 agonists in the treatment of chronic kidney disease in type 2 diabetes and obesity

The Journal of Clinical Investigation
Glucagon-like peptide-1 (GLP-1) was initially considered to be a hormone with a predominant role in regulating glucose metabolism by inducing insulin secretion, reducing glucagon secretion, and ameliorating insulin resistance, with the last effect being ...
Mark E. Cooper, Daniël H. van Raalte
doaj   +1 more source

Drugs for diabetes: part 6 GLP-1 receptor agonists

, 2011
The glucagon-like peptide-1 (GLP-1) receptor agonists are a new class of injected drugs for the treatment of type 2 diabetes. They mimic the action of GLP-1 and increase the incretin effect in patients with type 2 diabetes, stimulating the release of ...
Fisher, Miles, McKay, Gerard A., McDougall, Claire   +2 more
core  

Glucagon‐Like Peptide‐1 Receptor Agonists for Obstructive Sleep Apnea With and Without Continuous Positive Airway Pressure

Objective To evaluate glucagon‐like peptide 1 receptor agonists for obstructive sleep apnea compared with controls. Data Sources CINAHL, Cochrane Library ...
Cali Loblundo, Mohamed Abdelwahab, Sammy Y. Gao, Shaun A. Nguyen   +3 more
core   +1 more source

Prescription Sequence Symmetry Analysis of Glucagon-Like Peptide-1 Receptor Agonists and Neuropsychiatric Conditions. [PDF]

Clin Pharmacol Ther
Alfonso Arvez MJ, Wade S, Goordeen D, Ilomäki J, Cross AJ, Langiu M, Tan GSQ.   +6 more
europepmc   +1 more source

Pre-operative gastric volume measurement and glucagon-like peptide-1 receptor agonists. [PDF]

Anaesthesia
Lim ZJ, Dubey H, Munoz LM.
europepmc   +1 more source

Glucagon-like peptide-1 receptor agonists and venous thromboembolism: an unresolved question for Australian prescribers. [PDF]

Intern Med J
Kamel KS, Chan D, Hovelroud R.
europepmc   +1 more source